Song, P., Zhang, J., Shang, C., & Zhang, L. (2019). Curative effect assessment of immunotherapy for non‐small cell lung cancer: The “blind area” of Immune Response Evaluation Criteria in Solid Tumors (iRECIST). Thorac Cancer.
Citación estilo ChicagoSong, Peng, Jingcheng Zhang, Congcong Shang, y Li Zhang. "Curative Effect Assessment of Immunotherapy for Non‐small Cell Lung Cancer: The “blind Area” of Immune Response Evaluation Criteria in Solid Tumors (iRECIST)." Thorac Cancer 2019.
Cita MLASong, Peng, Jingcheng Zhang, Congcong Shang, y Li Zhang. "Curative Effect Assessment of Immunotherapy for Non‐small Cell Lung Cancer: The “blind Area” of Immune Response Evaluation Criteria in Solid Tumors (iRECIST)." Thorac Cancer 2019.
Precaución: Estas citas no son 100% exactas.